Osteogenic differentiation of human mesenchymal stem cells cultured with dexamethasone, vitamin D3, basic fibroblast growth factor, and bone morphogenetic protein-2

Connective Tissue Research

Volumn 53, Issue 2, 2012, Pages 117-131

  Mostafa, Nesrine Z ^a   Fitzsimmons, Ross ^a   Major, Paul W ^a   Adesida, Adetola ^a   Jomha, Nadr ^a   Jiang, Hongxing ^a   Uludaǧ, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adipogenesis; Bone tissue engineering; Craniofacial defects; Human mesenchymal stem cells; Osteogenesis

Indexed keywords

ADIPOCYTE PROTEIN 2; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CELL PROTEIN; COLECALCIFEROL; DEXAMETHASONE; FIBROBLAST GROWTH FACTOR 2; GLYCEROL 2 PHOSPHATE; OSTEONECTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SIALOPROTEIN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADIPOGENESIS; ADOLESCENT; ADULT; BONE DEVELOPMENT; CALCIFICATION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CONTROLLED STUDY; DNA CONTENT; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MINERALIZATION; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; STAINING; UPREGULATION;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE; BIOLOGICAL FACTORS; BIOLOGICAL MARKERS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CHOLECALCIFEROL; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION; GLYCEROPHOSPHATES; HUMANS; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOGENESIS; STEROIDS; TISSUE ENGINEERING; YOUNG ADULT;

EID: 84858255466     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.3109/03008207.2011.611601     Document Type: Review

References (45)

1. Waite, P.D., and Waite, D.E. (1996). Bone grafting for the alveolar cleft defect. Semin. Orthod. 2:192-196.
2. Moreau, J.L., Caccamese, J.F., Coletti, D.P., Sauk, J.J., and Fisher, J.P. (2007). Tissue engineering solutions for cleft palates. J. Oral. Maxillofac. Surg. 65:2503-2511. (Pubitemid 350110368)
3. Zuk, P.A. (2008). Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatr. Res. 63:478-486. (Pubitemid 351572216)
4. Logeart-Avramoglou, D., Anagnostou, F., Bizios, R., and Petite, H. (2005). Engineering bone: Challenges and obstacles. J. Cell Mol. Med. 9:72-84.
5. Rickard, D.J., Sullivan, T.A., Shenker, B.J., Leboy, P.S., and Kazhdan, I. (1994). Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev. Biol. 161:218-228. (Pubitemid 24049169)
6. Jorgensen, N.R., Henriksen, Z., Sorensen, O.H., and Civitelli, R. (2004). Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: Validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69:219-226. (Pubitemid 38748717)
7. Deifenderfer, D.L., Osyczka, A.M., Reilly, G.C., and Leboy, P.S. (2003). BMP responsiveness in human mesenchymal stem cells. Connect. Tissue Res. 44:305-311. (Pubitemid 36395462)
8. Jaiswal, N., Haynesworth, S.E., Caplan, A.I., and Bruder, S.P. (1997). Osteogenic differentiation of purified, cultureexpanded human mesenchymal stem cells in vitro. J. Cell Biochem. 64:295-312. (Pubitemid 27065443)
9. Hanada, K., Dennis, J.E., and Caplan, A.I. (1997). Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 12:1606-1614. (Pubitemid 27422361)
10. Wang, L., Huang, Y., Pan, K., Jiang, X., and Liu, C. (2010). Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann. Biomed. Eng. 38:77-87.
11. Takita, H., Tsuruga, E., Ono, I., and Kuboki, Y. (1997). Enhancement by bFGF of osteogenesis induced by rhBMP-2 in rats. Eur. J. Oral Sci. 105:588-592. (Pubitemid 127760552)
12. Fujimura, K., Bessho, K., Okubo, Y., Kusumoto, K., Segami, N., and Iizuka, T. (2002). The effect of fibroblast growth factor-2 on the osteoinductive activity of recombinant human bone morphogenetic protein-2 in rat muscle. Arch. Oral Biol. 47:577-584.
13. van Driel, M., Pols, H.A., and van Leeuwen, J.P. (2004). Osteoblast differentiation and control by vitamin D and vitamin D metabolites. Curr. Pharm. Des. 10:2535-2555. (Pubitemid 39004077)
14. Beresford, J.N., Joyner, C.J., Devlin, C., and Triffitt, J.T. (1994). The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch. Oral Biol. 39:941-947. (Pubitemid 124034578)
15. van Driel, M., Koedam, M., Buurman, C.J., Roelse, M., Weyts, F., Chiba, H., Uitterlinden, A.G., Pols, H.A., and van Leeuwen, J.P. (2006). Evidence that both 1alpha,25-dihydroxyvitamin D3 and 24-hydroxylated D3 enhance human osteoblast differentiation and mineralization. J. Cell Biochem. 99:922-935. (Pubitemid 44522009)
16. Kirsch, T., Nickel, J., and Sebald,W. (2000). B.M.P.-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II. Embo. J. 19:3314-3324. (Pubitemid 30428209)
17. Ruppert, R., Hoffmann, E., and Sebald, W. (1996). Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237: 295-302. (Pubitemid 26110301)
18. Frank, O., Heim, M., Jakob, M., Barbero, A., Schafer, D., Bendik, I., Dick, W., Heberer, M., and Martin, I. (2002). Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J. Cell. Biochem. 85:737-746. (Pubitemid 34462784)
19. Anderson, H.C. (1989). Mechanism of mineral formation in bone. Lab. Invest. 60:320-330. (Pubitemid 19095948)
20. Varkey, M., Kucharski, C., Doschak, M.R., Winn, S.R., Brochmann, E.J., Murray, S., Matyas, J.R., Zernicke, R.F., and Uludag H. (2007). Osteogenic response of bone marrow stromal cells from normal and ovariectomized rats treated with a low dose of basic fibroblast growth factor. Tissue Eng. 13:809-817. (Pubitemid 46651511)
21. Fromigue, O., Marie, P.J., and Lomri, A. (1997). Differential effects of transforming growth factor beta2, dexamethasone and 1,25-dihydroxyvitamin D on human bone marrow stromal cells. Cytokine 9:613-623. (Pubitemid 27348176)
22. Chaudhary, L.R., Hofmeister, A.M., and Hruska, K.A. (2004). Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 34:402-411. (Pubitemid 38314905)
23. Kim, I.S., Song, Y.M., Cho, T.H., Park, Y.D., Lee, K.B., Noh, I., Weber, F., and Hwang, S.J. (2008). In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev. Growth Differ. 50:553-564.
24. Piek, E., Sleumer, L.S., van Someren, E.P., Heuver, L., de Haan, J.R., de Grijs, I., Gilissen, C., Hendriks, J.M., van Ravestein-van Os, R.I., Bauerschmidt, S., Dechering, K.J., and van Zoelen, E.J. (2010). Osteo-transcriptomics of human mesenchymal stem cells: Accelerated gene expression and osteoblast differentiation induced by vitamin D reveals c-MYC as an enhancer of BMP2-induced osteogenesis. Bone 46(3):613-627.
25. Donahue, H.J., Li, Z., Zhou, Z., and Yellowley, C.E. (2000). Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am. J. Physiol. Cell Physiol. 278:C315-C22.
26. Hankemeier, S., Keus, M., Zeichen, J., Jagodzinski, M., Barkhausen, T., Bosch, U., Krettek, C., and Van Griensven, M. (2005). Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: Potential implications for tissue engineering of tendons and ligaments. Tissue Eng. 11:41-49. (Pubitemid 40515174)
27. Varkey,M., Kucharski, C., Haque, T., Sebald,W., and Uludag, H. (2006). In vitro osteogenic response of rat bone marrow cells to bFGF and BMP-2 treatments. Clin. Orthop. Relat. Res. 443:113-123. (Pubitemid 44324941)
28. Nuttall, M.E., Patton, A.J., Olivera, D.L., Nadeau, D.P., and Gowen, M. (1998). Human trabecular bone cells are able to express both osteoblastic and adipocytic phenotype: Implications for osteopenic disorders. J. Bone Miner. Res. 13: 371-382. (Pubitemid 28146219)
29. Bernlohr, D.A., Angus, C.W., Lane, M.D., Bolanowski, M.A., and Kelly Jr., T.J. (1984). Expression of specific mRNAs during adipose differentiation: Identification of an mRNA encoding a homologue of myelin P2 protein. Proc. Natl. Acad. Sci. USA. 81:5468-5472. (Pubitemid 14000508)
30. Ross, S.R., Graves, R.A., Greenstein, A., Platt, K.A., Shyu, H.L., Mellovitz, B., and Spiegelman, B.M. (1990). A fatspecific enhancer is the primary determinant of gene expression for adipocyte P2 in vivo. Proc. Natl. Acad. Sci. USA. 87:9590-9594. (Pubitemid 120016489)
31. Bellows, C.G., Wang, Y.H., Heersche, J.N., and Aubin, J.E. (1994). 1,25-dihydroxyvitamin D3 stimulates adipocyte differentiation in cultures of fetal rat calvaria cells: Comparison with the effects of dexamethasone. Endocrinology 134: 2221-2229.
32. Mikami, Y., Lee, M., Irie, S., and Honda, M.J. (2011). Dexamethasone modulates osteogenesis and adipogenesis with regulation of osterix expression in rat calvaria-derived cells. J. Cell. Physiol. 226:739-748.
33. Shen, B., Wei, A., Whittaker, S., Williams, L.A., Tao, H., Ma, D.D.F., and Diwan, A.D. (2010). The role of BMP-7 in chondrogenic and osteogenic differentiation of human bone marrow multipotent mesenchymal stromal cells in vitro. J. Cell Biochem. 109:406-416.
34. Neumann, K., Endres, M., Ringe, J., Flath, B., Manz, R., Haupl, T., Sittinger, M., and Kaps, C. (2007). BMP7 promotes adipogenic but not osteo-/chondrogenic differentiation of adult human bone marrow-derived stem cells in high-density micro-mass culture. J. Cell Biochem. 102:626-637. (Pubitemid 47557417)
35. Akita, S., Fukui, M., Nakagawa, H., Fujii, T., and Akino, K. (2004). Cranial bone defect healing is accelerated by mesenchymal stem cells induced by coadministration of bone morphogenetic protein-2 and basic fibroblast growth factor. Wound Repair Regen. 12:252-259. (Pubitemid 38520692)
36. Prockop, D.J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74. (Pubitemid 27161245)
37. Komori, T. (2010). Regulation of bone development and extracellular matrix protein genes by RUNX2. Cell Tissue Res. 339:189-195.
38. Setzer, B., Bachle, M., Metzger, M.C., and Kohal, R.J. (2009). The gene-expression and phenotypic response of hFOB 1.19 osteoblasts to surface-modified titanium and zirconia. Biomaterials 30:979-990.
39. Titorencu, I., Jinga, V.V., Constantinescu, E., Gafencu, A.V., Ciohodaru, C., Manolescu, I., Zaharia, C., and Simionescu, M. (2007). Proliferation, differentiation and characterization of osteoblasts from human BM mesenchymal cells. Cytotherapy 9:682-696. (Pubitemid 47604658)
40. Mankani, M.H., Kuznetsov, S.A., Wolfe, R.M., Marshall, G.W., and Robey, P.G. (2006). In vivo bone formation by human bone marrow stromal cells: Reconstruction of the mouse calvarium and mandible. Stem Cells 24:2140-2149. (Pubitemid 44477139)
41. Bidic, S.M., Calvert, J.W., Marra, K., Kumta, P., Campbell, P., Mitchell, R., Wigginton, W., Hollinger, J.O., Weiss, L., and Mooney, M.P. (2003). Rabbit calvarial wound healing by means of seeded Caprotite scaffolds. J. Dent. Res. 82: 131-135. (Pubitemid 41764125)
42. Burastero, G., Scarfì, S., Ferraris, C., Fresia, C., Sessarego, N., Fruscione, F., Monetti, F., Scarfò, F., Schupbach, P., Podestà, M., Grappiolo, G., and Zocchi, E. (2010). The association of human mesenchymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. Bone 47(1):117-126.
43. Gimbel, M., Ashley, R.K., Sisodia, M., Gabbay, J.S., Wasson, K.L., Heller, J., Wilson, L., Kawamoto, H.K., and Bradley, J.P. (2007). Repair of alveolar cleft defects: Reduced morbidity with bone marrow stem cells in a resorbable matrix. J. Craniofac. Surg. 18:895-901. (Pubitemid 47220752)
44. Behnia, H., Khojasteh, A., Soleimani, M., Tehranchi, A., Khoshzaban, A., Keshel, S.H., and Atashi, R. (2009). Secondary repair of alveolar clefts using human mesenchymal stem cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 108:e1-6.
45. Hibi, H., Yamada, Y., Ueda,M., and Endo, Y. (2006). Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int. J. Oral Maxillofac. Surg. 35:551-555.